Design Therapeutics, Inc. (DSGN)

13.16 +0.04 (+0.30%) USD  |  NASDAQ  |  Apr 20, 16:00
13.29 +0.13 (+0.99%) After-Hours: 20:00
More

Design Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for DSGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Theravance Biopharma, Inc. Upgrade
vTv Therapeutics, Inc. Upgrade
Tactile Systems Technology, Inc. Upgrade
Immuneering Corp. Upgrade
X4 Pharmaceuticals, Inc. Upgrade